Abviris Deutschland GmbH

The biotechnology company Abviris Deutschland GmbH, based in Ahrensburg, Germany, is a pioneer in HPV serology, developing innovative, next generation, products such as Prevo-Check® for early detection and post-treatment monitoring of HPV-induced tumours. Prevo-Check® makes it possible to easily detect precancerous lesions from a drop of blood, thereby helping patients to improve their quality of life and chances of survival. We use our knowledge in HPV diagnostics realising an optimal cancer patient management. Abviris addresses the globally increasing problem of cancer caused by the human papillomavirus (HPV). We are dedicated to improving the clinical outcomes of patients and enable clinicians worldwide to fight HPV-induced tumours, including head and neck cancer, penile and anal tumours, vaginal and vulvar cancer and of course cervical cancer.